{"DataElement":{"publicId":"7748949","version":"1","preferredName":"Melanoma Tumor Regression Assessment Outcome","preferredDefinition":"An evaluation of the presence or degree of tumor regression present in an atypical, neoplastic melanocytes sample.","longName":"7748948v1.0:7642805v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7748948","version":"1","preferredName":"Melanoma Tumor Regression Assessment","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain._An evaluation of the presence or degree of tumor regression present in a sample.","longName":"3108463v1.0:7748946v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"3108463","version":"1","preferredName":"Melanoma","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004","longName":"C3224","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"888ED2DC-38AD-7A5E-E040-BB89AD4317F2","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7748946","version":"1","preferredName":"Tumor Regression Assessment","preferredDefinition":"An evaluation of the presence or degree of tumor regression present in a sample.","longName":"C178046","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Regression Assessment","conceptCode":"C178046","definition":"An evaluation of the presence or degree of tumor regression present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C81B9BDB-F995-3B40-E053-4EBD850ADF27","latestVersionIndicator":"Yes","beginDate":"2021-07-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-07-27","modifiedBy":"ONEDATA","dateModified":"2021-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2183452","version":"6","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease","longName":"ASSESSMENTS","context":"TEST","contextVersion":"1","origin":null,"workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"DC2065AE-57FE-47D7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-05","endDate":"2022-05-24","createdBy":"JASUR","dateCreated":"2004-06-05","modifiedBy":"DWARZEL","dateModified":"2022-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C81B9BDB-F9A6-3B40-E053-4EBD850ADF27","latestVersionIndicator":"Yes","beginDate":"2021-07-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-07-27","modifiedBy":"KNABLEJ","dateModified":"2021-07-30","changeDescription":"7/27/21 jk created for Phase 3 CM Baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7642805","version":"1","preferredName":"Present Not Identified Indeterminate Outcome","preferredDefinition":"Being or existing in a specified place or at the specified time._The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context._Cannot distinguish between two or more possible values in the current context._The result of an action.","longName":"7642805v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Present","valueDescription":"Present","ValueMeaning":{"publicId":"2570604","version":"1","preferredName":"Present","longName":"2570604","preferredDefinition":"Being or existing in a specified place or at the specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E0D9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"MAESKEB","dateModified":"2019-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E6767D-B157-78F5-E053-4EBD850AB91D","beginDate":"2021-04-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"},{"value":"Not identified","valueDescription":"Not Identified","ValueMeaning":{"publicId":"2581153","version":"1","preferredName":"Not Identified","longName":"2581153","preferredDefinition":"The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Identified","conceptCode":"C48661","definition":"The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E6767D-B14C-78F5-E053-4EBD850AB91D","beginDate":"2021-04-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate or Unknown","ValueMeaning":{"publicId":"6841632","version":"1","preferredName":"Indeterminate or Unknown","longName":"6841632","preferredDefinition":"An indication that something is indeterminate or unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate or Unknown","conceptCode":"C157157","definition":"An indication that something is indeterminate or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFB6B26-0C86-5A31-E053-F662850A5C7D","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E7B796-B51E-633F-E053-4EBD850AB9C4","beginDate":"2021-04-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7642804","version":"1","preferredName":"Present Not Identified Indeterminate Outcome","preferredDefinition":"Being or existing in a specified place or at the specified time.:The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context.:Cannot distinguish between two or more possible values in the current context.:The result of an action.","longName":"C25626:C48661:C48658:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Not Identified","conceptCode":"C48661","definition":"The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E6767D-B10F-78F5-E053-4EBD850AB91D","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E6767D-B120-78F5-E053-4EBD850AB91D","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-26","modifiedBy":"SOKKERL","dateModified":"2023-09-24","changeDescription":"4/26/21 jk created for Phase 3 CM Baseline CRF.","administrativeNotes":"Admin: 9/23/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Regression","type":"Preferred Question Text","description":"Tumor Regression","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C81C63EB-20AE-3FF7-E053-4EBD850A75FE","latestVersionIndicator":"Yes","beginDate":"2021-07-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-07-27","modifiedBy":"KNABLEJ","dateModified":"2021-07-30","changeDescription":"7/28/21 jk upd sys gen def.  7/26/21 jk created for Phase 3 CM Baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}